Guiding-Agent-Conjugated Field-Electric Nanoparticles for Targeted Pathogen Disruption

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods lack an effective way to generate a localized electric field strong enough to disrupt or destroy viruses, bacteria, or fungus within a biological body without harming surrounding healthy cells, especially for novel viruses and antibiotic-resistant infections.

Innovation Solution

The development of Guiding-Agent-Conjugated Field-Electric Nanoparticles (GAC-FENPs) that are delivered to target sites and activated by an external energy field to produce a localized electric field, using nanoparticles like Magneto-Electric Nano-Particles (MENPs) with a core-shell structure, which generate electric fields strong enough to disrupt targeted pathogens while minimizing damage to healthy cells.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If a strong electric field is applied to disrupt or destroy pathogens, then the antimicrobial effect is improved, but surrounding healthy cells are damaged

Engineering Contradiction:
Improveantimicrobial effectVSAvoiddamage to healthy cells
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent applies local quality by concentrating the electric field generation at the specific location of pathogens through Guiding-Agent-Conjugated Field-Electric Nanoparticles. The guiding agents (antibodies, ligands, or peptides) enable the nanoparticles to target and bind specifically to pathogens, creating a localized electric field only at the infection site rather than applying a global electric field to the entire body, thus protecting healthy cells from damage.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent uses guiding agents as intermediaries between the electric field generation system and the pathogens. These guiding agents (such as antibodies or ligands) mediate the specific recognition and binding of nanoparticles to target pathogens, enabling selective delivery of the electric field effect only to infected cells while sparing healthy tissue.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Adaptability or versatility

If conventional antimicrobial treatments are used, then common infections are treated, but novel viruses and antibiotic-resistant infections remain untreated

Engineering Contradiction:
Improvetreatment coverageVSAvoidtreatment effectiveness
Core Design Contradiction:
Adaptability or versatilityVSReliability

Solution Approach 1:

The patent achieves universality by designing a platform technology that can treat multiple types of pathogens including bacteria, viruses, and fungus through a common mechanism of electric field disruption. The system can be adapted to target different pathogens by changing the guiding agent conjugation, making it effective against both common infections and novel or antibiotic-resistant strains without requiring pathogen-specific drugs.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The patent applies parameter changes by utilizing the physical property of electric fields to disrupt pathogen functions. Unlike chemical antibiotics that rely on biochemical pathways, the electric field mechanism physically disrupts cellular membranes and functions, making it effective against pathogens that have developed resistance to conventional chemical treatments.

Inventive Principle:
Principle #35Parameter changes

3Object-affected harmful factors

If a localized electric field is generated at the pathogen site, then healthy cells are protected, but the complexity of the apparatus increases

Engineering Contradiction:
Improveprotection of healthy cellsVSAvoidapparatus structure
Core Design Contradiction:
Object-affected harmful factorsVSDevice complexity

Solution Approach 1:

The patent applies segmentation by dividing the treatment system into separate functional components: (1) nanoparticles with guiding agents for target recognition and delivery, and (2) an external energy field generation module for activating the electric field effect. This segmentation allows the complex functions to be distributed and coordinated, making the overall system manageable despite its complexity.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent uses the nested doll principle by incorporating multiple functional layers within the nanoparticle structure. The nanoparticles contain guiding agents conjugated to Field-Electric Nano-Particles, creating a nested configuration where the guiding agent layer enables specific targeting while the core FENP generates the electric field effect when activated by external energy.

Inventive Principle:
Principle #7Nested doll (Nesting)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach effectively disrupts or destroys targeted pathogens while avoiding damage to healthy cells, providing a novel treatment for various viral, bacterial, and fungal infections, including antibiotic-resistant strains and novel viruses like Ebola and COVID-19-related black fungus.

Implementation Method 1

using localized electric field generated by types of nanoparticles converting energy from an applied external field

Methodology Applied
Scientific EffectElectromagnetic energy conversion to electric field: Electromagnetic Induction

Implementation Method 2

using nanoparticles like Magneto-Electric Nano-Particles (MENPs) with a core-shell structure, which generate electric fields strong enough to disrupt targeted pathogens

Methodology Applied
Scientific EffectMagneto-electric effect: Magnetoelastic Effects

Data Source

PatentUS20210369844A1Antimicrobial apparatus comprising field-electric nanoparticles (FENPS) and method thereof
Publication Date: 2021.12.02 LIANG PING
  • US20210369844A1 patent drawing
  • US20210369844A1 patent drawing
  • US20210369844A1 patent drawing

AI summary

The present invention provides an apparatus for targeting and disrupting, deactivating or destroying microorganisms (e.g. viruses, bacteria, fungus or diseased cells). The apparatus includes Field-Electric Nano-Particles coated, conjugated or functionalized with one or more guiding agents such as antibodies or proteins that target a type of bacteria, fungus, virus or diseased cells; a delivery module to deliver such nanoparticles into a subject's body, and an external energy field generation module. The nanoparticles, when subject to the applied external energy field, generate an electric field or pulses of electric field localized to the targeted bacteria, fungus or virus to disrupt, deactivate or destroy the targeted bacteria, fungus, viruses, or diseased cells.